FDA Issues Final Guidance on Drug-Drug Interaction Studies for Oral Contraceptives

The FDA has finalized its guidance on drug-drug interaction (DDI) studies of investigational drugs with combined oral contraceptives (COC), outlining when these studies are and aren’t needed, how to design them and how to communicate findings.
Source: Drug Industry Daily